In addition to acting on GLP-1 receptors, tirzepatide also targets GIP receptors located in the pancreas, adipose (fat) tissue, and brain regions involved in eating behavior and insulin regulation
Semaglutide/Tirzepatide will delay gastric emptying by reducing glucagon secretion in a glucose-dependent manner
People with active pancreatitis or a history of pancreatitis should approach tirzepatide with extreme caution and only under close medical supervision
All together, these actions can reduce your appetite, make you feel fuller for longer, reduce cravings, and help you eat less
state-licensed providers and compounding pharmacies
Your healthcare provider might also suggest combining semaglutide with another therapy to address any underlying causes of the cramps